查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1423186

2024-2032年按治疗类型（皮下免疫疗法、舌下免疫疗法）、过敏类型、配销通路和地区分類的过敏免疫疗法市场报告

Allergy Immunotherapies Market Report by Treatment Type (Subcutaneous Immunotherapy, Sublingual Immunotherapy ), Allergy Type, Distribution Channel, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 141 Pages | 商品交期: 2-3个工作天内

价格

2023年全球过敏免疫疗法市场规模达31亿美元。展望未来， IMARC Group预计到2032年市场规模将达到67亿美元，2024-2032年复合年增长率（CAGR）为8.7%。

过敏免疫治疗，也称为脱敏或低敏治疗，是针对过敏原（包括各种食物、药物、蜂毒、草花粉和屋尘螨）的过敏反应的预防性医学治疗。它透过逐渐增加过敏原的剂量来改变免疫系统的反应。在治疗开始之前，过敏症专家和患者会分析过敏症状的触发因素，其中可能涉及皮肤和血液检查以确认过敏原。过敏免疫疗法有助于减少发炎、提供长期影响、提高免疫耐受性、改变病程并改善患者的生活品质。

近年来，由于影响免疫系统功能的各种环境和生活方式因素，世界各地过敏的盛行率有所上升。随着人们对过敏免疫疗法的认识不断增强、收入水平的提高和医疗保健支出的增加，对复杂和长期治疗方案的需求不断增加，这反过来又刺激了市场的成长。由于世界各地政府和非政府组织采取的多项倡议，临床研究和开发预算不断增加，进一步支持了这一点。此外，利用最新的药物开发技术，製药公司已经创造了更有效的免疫疗法，可以成功治疗一系列过敏。再加上过敏诊断领域的进步，正在促进全球过敏免疫疗法市场的成长。

本报告回答的关键问题

  • 2023年全球过敏免疫疗法市场规模有多大？
  • 2024-2032年全球过敏免疫治疗市场的预期成长率是多少？
  • 推动全球过敏免疫治疗市场的关键因素是什么？
  • COVID-19 对全球过敏免疫疗法市场有何影响？
  • 根据治疗类型，全球过敏免疫疗法市场的细分如何？
  • 根据过敏类型，全球过敏免疫治疗市场的细分如何？
  • 基于配销通路的全球过敏免疫治疗市场的细分情况如何？
  • 全球过敏免疫治疗市场的关键地区有哪些？
  • 谁是全球过敏免疫治疗市场的主要参与者/公司？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球过敏免疫疗法市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场区隔：按治疗类型
  • 市场区隔：依过敏类型
  • 市场区隔：按配销通路
  • 市场区隔：按地区
  • 市场预测

第 6 章：市场区隔：依治疗类型

  • 皮下免疫疗法（SCIT）
    • 市场走向
    • 市场预测
  • 舌下免疫疗法（SLIT）
    • 市场走向
    • 市场预测

第 7 章：市场区隔：依过敏类型

  • 过敏性鼻炎
    • 市场走向
    • 市场预测
  • 气喘
    • 市场走向
    • 市场预测
  • 食物过敏
    • 市场走向
    • 市场预测
  • 毒液过敏
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 8 章：市场区隔：按配销通路

  • 医院药房
    • 市场走向
    • 市场预测
  • 零售药房
    • 市场走向
    • 市场预测
  • 网路药房
    • 市场走向
    • 市场预测

第 9 章：市场区隔：按地区

  • 欧洲
    • 市场走向
    • 市场预测
  • 北美洲
    • 市场走向
    • 市场预测
  • 亚太地区
    • 市场走向
    • 市场预测
  • 中东和非洲
    • 市场走向
    • 市场预测
  • 拉丁美洲
    • 市场走向
    • 市场预测

第 10 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 11 章：价值链分析

第 12 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 13 章：价格分析

  • 价格指标
  • 价格结构
  • 利润分析

第14章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • ALK-Abello A/S
    • Allergy Therapeutics
    • Stallergenes Greer
    • HAL Allergy Holding BV
    • DBV Technologies
    • Merck KGaA
    • Aimmune Therapeutics
    • Circassia Pharmaceuticals
    • Anergis SA
    • Biomay AG
Product Code: SR112024A1401

Abstract

The global allergy immunotherapies market size reached US$ 3.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 6.7 Billion by 2032, exhibiting a growth rate (CAGR) of 8.7% during 2024-2032.

Allergy immunotherapy, also known as desensitization or hypo-sensitization, is a preventive medical treatment for allergic reactions to allergens including various foods, drugs, bee venom, grass pollens and house dust mites. It alters the immune system's response by gradually increasing the doses of the allergen. Before the treatment begins, an allergist and patient analyze triggering factors for allergy symptoms, which may involve skin and blood tests to confirm the allergens. Allergy immunotherapy helps in reducing inflammation, offering long-term impact, increasing immunological tolerance, changing the course of the disease and improving the quality of the patient's life.

In recent years, there has been a rise in the prevalence of allergies around the world on account of various environmental and lifestyle factors that influence the functioning of the immune system. With the growing awareness of allergy immunotherapies, elevating income levels and increasing healthcare expenditure, the demand for sophisticated and long-term treatment options is increasing, which in turn is stimulating the growth of the market. It is further supported by the rising clinical research and development budget owing to several initiatives undertaken by both governmental and non-governmental organizations around the world. Further, with the latest drug development technologies, pharmaceutical firms have created more efficient immunotherapies for treating an array of allergies successfully. This, coupled with advancements in the field of allergy diagnostics, is catalyzing the global allergy immunotherapies market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global allergy immunotherapies market report, along with forecasts at the global and regional level from 2024-2032. Our report has categorized the market based on treatment type, allergy type and distribution channel.

Breakup by Treatment Type:

Subcutaneous Immunotherapy (SCIT)

Sublingual Immunotherapy (SLIT)

Breakup by Allergy Type:

Allergic Rhinitis

Asthma

Food Allergy

Venom Allergy

Others

Breakup by Distribution Channel:

Hospital Pharmacy

Retail Pharmacy

Online Pharmacy

Breakup by Region:

Europe

North America

Asia Pacific

Middle East and Africa

Latin America

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being ALK-Abello A/S, Allergy Therapeutics, Stallergenes Greer, HAL Allergy Holding B.V., DBV Technologies, Merck KGaA, Aimmune Therapeutics, Circassia Pharmaceuticals, Anergis SA, and Biomay AG, etc.

Key Questions Answered in This Report

  • 1. What was the size of the global allergy immunotherapies market in 2023?
  • 2. What is the expected growth rate of the global allergy immunotherapies market during 2024-2032?
  • 3. What are the key factors driving the global allergy immunotherapies market?
  • 4. What has been the impact of COVID-19 on the global allergy immunotherapies market?
  • 5. What is the breakup of the global allergy immunotherapies market based on the treatment type?
  • 6. What is the breakup of the global allergy immunotherapies market based on the allergy type?
  • 7. What is the breakup of the global allergy immunotherapies market based on the distribution channel?
  • 8. What are the key regions in the global allergy immunotherapies market?
  • 9. Who are the key players/companies in the global allergy immunotherapies market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Allergy Immunotherapies Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Breakup by Treatment Type
  • 5.5 Market Breakup by Allergy Type
  • 5.6 Market Breakup by Distribution Channel
  • 5.7 Market Breakup by Region
  • 5.8 Market Forecast

6 Market Breakup by Treatment Type

  • 6.1 Subcutaneous Immunotherapy (SCIT)
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Sublingual Immunotherapy (SLIT)
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Allergy Type

  • 7.1 Allergic Rhinitis
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Asthma
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Food Allergy
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Venom Allergy
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Hospital Pharmacy
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Retail Pharmacy
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Online Pharmacy
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 Europe
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 North America
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Asia Pacific
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Middle East and Africa
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Latin America
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

  • 13.1 Price Indicators
  • 13.2 Price Structure
  • 13.3 Margin Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 ALK-Abello A/S
    • 14.3.2 Allergy Therapeutics
    • 14.3.3 Stallergenes Greer
    • 14.3.4 HAL Allergy Holding B.V.
    • 14.3.5 DBV Technologies
    • 14.3.6 Merck KGaA
    • 14.3.7 Aimmune Therapeutics
    • 14.3.8 Circassia Pharmaceuticals
    • 14.3.9 Anergis SA
    • 14.3.10 Biomay AG

List of Figures

  • Figure 1: Global: Allergy Immunotherapies Market: Major Drivers and Challenges
  • Figure 2: Global: Allergy Immunotherapies Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Allergy Immunotherapies Market: Breakup by Treatment Type (in %), 2023
  • Figure 4: Global: Allergy Immunotherapies Market: Breakup by Allergy Type (in %), 2023
  • Figure 5: Global: Allergy Immunotherapies Market: Breakup by Distribution Channel (in %), 2023
  • Figure 6: Global: Allergy Immunotherapies Market: Breakup by Region (in %), 2023
  • Figure 7: Global: Allergy Immunotherapies Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 8: Global: Allergy Immunotherapies Industry: SWOT Analysis
  • Figure 9: Global: Allergy Immunotherapies Industry: Value Chain Analysis
  • Figure 10: Global: Allergy Immunotherapies Industry: Porter's Five Forces Analysis
  • Figure 11: Global: Allergy Immunotherapies (Subcutaneous Immunotherapy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Allergy Immunotherapies (Subcutaneous Immunotherapy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Allergy Immunotherapies (Sublingual Immunotherapy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Allergy Immunotherapies (Sublingual Immunotherapy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Allergy Immunotherapies (Allergic Rhinitis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Allergy Immunotherapies (Allergic Rhinitis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Allergy Immunotherapies (Asthma) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Allergy Immunotherapies (Asthma) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Allergy Immunotherapies (Food Allergy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Allergy Immunotherapies (Food Allergy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Allergy Immunotherapies (Venom Allergy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Allergy Immunotherapies (Venom Allergy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Allergy Immunotherapies (Other Allergy Types) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Allergy Immunotherapies (Other Allergy Types) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Allergy Immunotherapies Market: Sales through Hospital Pharmacy (in Million US$), 2018 & 2023
  • Figure 26: Global: Allergy Immunotherapies Market Forecast: Sales through Hospital Pharmacy (in Million US$), 2024-2032
  • Figure 27: Global: Allergy Immunotherapies Market: Sales through Retail Pharmacy (in Million US$), 2018 & 2023
  • Figure 28: Global: Allergy Immunotherapies Market Forecast: Sales through Retail Pharmacy (in Million US$), 2024-2032
  • Figure 29: Global: Allergy Immunotherapies Market: Online Sales (in Million US$), 2018 & 2023
  • Figure 30: Global: Allergy Immunotherapies Market Forecast: Online Sales (in Million US$), 2024-2032
  • Figure 31: Europe: Allergy Immunotherapies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Europe: Allergy Immunotherapies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: North America: Allergy Immunotherapies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: North America: Allergy Immunotherapies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Asia Pacific: Allergy Immunotherapies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Asia Pacific: Allergy Immunotherapies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Middle East and Africa: Allergy Immunotherapies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Middle East and Africa: Allergy Immunotherapies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: Latin America: Allergy Immunotherapies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: Latin America: Allergy Immunotherapies Market Forecast: Sales Value (in Million US$), 2024-2032

List of Tables

  • Table 1: Global: Allergy Immunotherapies Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Allergy Immunotherapies Market Forecast: Breakup by Treatment Type (in Million US$), 2024-2032
  • Table 3: Global: Allergy Immunotherapies Market Forecast: Breakup by Allergy Type (in Million US$), 2024-2032
  • Table 4: Global: Allergy Immunotherapies Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
  • Table 5: Global: Allergy Immunotherapies Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Allergy Immunotherapies Market Structure
  • Table 7: Global: Allergy Immunotherapies Market: Key Players